IND-2, a Quinoline Derivative, Inhibits the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress,

Swapnaa Balaji1, Rabin Neupane1, Saloni Malla1

  • 1Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Life (Basel, Switzerland)
|November 26, 2022
PubMed

Insights

IND-2, a novel compound, effectively inhibits prostate cancer (PC) cell growth and induces apoptosis. This research highlights IND-2 as a promising candidate for developing new PC treatments with fewer side effects.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Prostate cancer (PC) is a leading cause of cancer-related deaths in men, with current treatments facing challenges like drug resistance and adverse effects.
  • Novel therapeutic agents are urgently needed for effective PC treatment, especially for metastatic cases.
  • Condensed quinolines represent a class of natural compounds with known anticancer properties.

Purpose of the Study:

  • To evaluate the in vitro anticancer efficacy of IND-2, a novel condensed quinoline derivative, against human prostate cancer cell lines (PC-3 and DU-145).
  • To elucidate the mechanisms underlying IND-2's anti-proliferative effects, including its impact on apoptosis, mitochondrial function, and cell cycle progression.

Main Methods:

  • In vitro assays were performed on PC-3 and DU-145 prostate cancer cell lines.
  • Cell proliferation was assessed using IC50 values.
  • Apoptosis was evaluated by measuring mitochondrial membrane potential, caspase activation, Bcl-2 expression, and observing morphological changes.
  • Mitotic catastrophe, reactive oxygen species (ROS) levels, and topoisomerase IIα activity were also analyzed.

Main Results:

  • IND-2 demonstrated significant inhibition of PC-3 and DU-145 cell proliferation with IC50 values of 3 µM and 3.5 µM, respectively.
  • IND-2 induced apoptosis in PC-3 cells by decreasing mitochondrial membrane potential, increasing cleaved caspase-3, -7, and PARP, and reducing Bcl-2 expression.
  • IND-2 triggered mitotic catastrophe in PC-3 cells, elevated ROS levels in DU-145 cells, and inhibited topoisomerase IIα activity.

Conclusions:

  • IND-2 exhibits potent in vitro anticancer activity against prostate cancer cell lines through multiple mechanisms, including apoptosis induction and mitotic catastrophe.
  • The findings suggest that IND-2 has the potential to be a lead compound for developing novel and more efficacious prostate cancer therapeutics.
  • Further research into IND-2 could pave the way for new treatment strategies targeting drug-resistant and metastatic prostate cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K